KYORIN Holdings Inc (4569) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

KYORIN Holdings Inc (4569) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH61092D
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries out the discovery, manufacturing and sale of pharmaceuticals including new ethical drugs, generic drugs and the over-the-counter (OTC) drugs. It also provides consumer healthcare products including beauty and good health products. KYORIN provides product under Kipres, Mucodyne, Pentasa, Uritos, Ketas, Flutiform, Milton, Rubysta and other brands. KYORIN is headquartered in Chiyoda-Ku, Tokyo, Japan.

KYORIN Holdings Inc (4569)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

KYORIN Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Kyorin Acquires Production Facility from MSD 11

Partnerships 12

Kyorin Pharma Enters into Development and Distribution Agreement with Faes Farma 12

MSD Enters into Distribution Agreement with Kyorin Pharma 13

MSD Enters into Agreement with Kyorin Pharma 14

Kyorin Pharma to Enter into Co-Promotion Agreement with Kaken Pharma 15

Kissei Pharma Enters into Agreement with Kyorin Pharma 16

Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 17

Kyorin Pharma Enters into Co-Marketing Agreement with Yoshida Pharma 18

Kyorin Pharma Amends Co-Marketing Agreement with MSD 19

Eisai Enters into Agreement with Kyorin 20

Kyorin Pharma Enters Into Research Agreement With BioLeap 21

Licensing Agreements 22

Kyorin Pharma Enters into Licensing Agreement with Sanwa Kagaku 22

KYORIN Rimedio Enters into a Licensing Agreement with Binh Dinh Pharma 23

Kyorin Pharma Enters into Licensing Agreement with Merck 24

Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 25

Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 26

Synmosa Biopharma Enters into Licensing Agreement with Kyorin Pharma 27

R-Pharm Enters into Licensing Agreement with Kyorin Pharma for Imidafenacin 28

Kyorin Pharma Enters into Licensing Agreement with Merck 29

Asset Transactions 30

Galderma Acquires Pekiron Cream From Kyorin Pharma 30

Acquisition 31

Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 31

Teijin Acquires 10% Stake In Kyorin For USD 197 Million 32

KYORIN Holdings Inc-Key Competitors 33

KYORIN Holdings Inc-Key Employees 34

KYORIN Holdings Inc-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 36

Other Significant Developments 36

Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Kyorin 36

Feb 22, 2017: Kyorin Holdings: Establishment of a Representative Office in the Republic of Indonesia 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

KYORIN Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

KYORIN Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8

KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Kyorin Acquires Production Facility from MSD 11

Kyorin Pharma Enters into Development and Distribution Agreement with Faes Farma 12

MSD Enters into Distribution Agreement with Kyorin Pharma 13

MSD Enters into Agreement with Kyorin Pharma 14

Kyorin Pharma to Enter into Co-Promotion Agreement with Kaken Pharma 15

Kissei Pharma Enters into Agreement with Kyorin Pharma 16

Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 17

Kyorin Pharma Enters into Co-Marketing Agreement with Yoshida Pharma 18

Kyorin Pharma Amends Co-Marketing Agreement with MSD 19

Eisai Enters into Agreement with Kyorin 20

Kyorin Pharma Enters Into Research Agreement With BioLeap 21

Kyorin Pharma Enters into Licensing Agreement with Sanwa Kagaku 22

KYORIN Rimedio Enters into a Licensing Agreement with Binh Dinh Pharma 23

Kyorin Pharma Enters into Licensing Agreement with Merck 24

Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 25

Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 26

Synmosa Biopharma Enters into Licensing Agreement with Kyorin Pharma 27

R-Pharm Enters into Licensing Agreement with Kyorin Pharma for Imidafenacin 28

Kyorin Pharma Enters into Licensing Agreement with Merck 29

Galderma Acquires Pekiron Cream From Kyorin Pharma 30

Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 31

Teijin Acquires 10% Stake In Kyorin For USD 197 Million 32

KYORIN Holdings Inc, Key Competitors 33

KYORIN Holdings Inc, Key Employees 34

KYORIN Holdings Inc, Subsidiaries 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

KYORIN Holdings Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 18445
Site License
USD 500 INR 36890
Corporate User License
USD 750 INR 55335

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com